2. CKD3-banner 5000X625 px

Bio Preventive Medicine Corp. (BPM) is a leading company in novel renal biomarker area. BPM focuses on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially in diabetic kidney disease (DKD) and non-proteinuric renal disease. BPM’s CE IVD marked DNlite-IVD103 is a urinary test for effectively predicting/ monitoring the progression of DKD by detecting a post translational modification of a unique DKD biomarker. We can assist our partners realize the efficiency in product development through use of BPM’s expertise in translational medicine.

Dr. Tseng

Tzu-ling (Karen) Tseng

Chief Executive Officer


Howie Yiu

Sales and Marketing Director